Source:http://linkedlifedata.com/resource/pubmed/id/20477946
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007577,
umls-concept:C0150312,
umls-concept:C0205234,
umls-concept:C0205263,
umls-concept:C0205360,
umls-concept:C0332206,
umls-concept:C0677647,
umls-concept:C0678226,
umls-concept:C0678594,
umls-concept:C1364818,
umls-concept:C1533134,
umls-concept:C1704259,
umls-concept:C1705987,
umls-concept:C2349975
|
pubmed:issue |
3
|
pubmed:dateCreated |
2010-7-26
|
pubmed:abstractText |
Epidemiological studies have shown an association between statin use and a decreased risk of dementia. However, the mechanism by which this beneficial effect is brought about is unclear. In the context of Alzheimer's disease, at least three possibilities have been studied; reduction in amyloid beta peptide (Abeta) production, the promotion of alpha-secretase cleavage and positive effects on neurite outgrowth. By investigating the effects of mevalonate pathway blockade on neurite outgrowth using real-time imaging, we found that rather than promote the production of neurite extensions, inhibition rapidly induced cell rounding. Crucially, neurite-like structures were generated through the persistence of cell-cell and cell-substrate adhesions and not through a mechanism of positive outgrowth. This effect can be strikingly enhanced by the over-expression of human amyloid precursor protein and is isoprenoid rather than cholesterol dependent.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1471-4159
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
114
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
832-42
|
pubmed:meshHeading |
pubmed-meshheading:20477946-Alzheimer Disease,
pubmed-meshheading:20477946-Amyloid beta-Protein Precursor,
pubmed-meshheading:20477946-Cell Adhesion,
pubmed-meshheading:20477946-Cell Line, Tumor,
pubmed-meshheading:20477946-Cell Shape,
pubmed-meshheading:20477946-Humans,
pubmed-meshheading:20477946-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:20477946-Mevalonic Acid,
pubmed-meshheading:20477946-Microscopy, Video,
pubmed-meshheading:20477946-Neurites,
pubmed-meshheading:20477946-Neuroblastoma,
pubmed-meshheading:20477946-Neurogenesis
|
pubmed:year |
2010
|
pubmed:articleTitle |
Neurite-like structures induced by mevalonate pathway blockade are due to the stability of cell adhesion foci and are enhanced by the presence of APP.
|
pubmed:affiliation |
Pharmaceutical Sciences Division, King's College London, London, UK.
|
pubmed:publicationType |
Journal Article
|